| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M610919200 |
| P698 | PubMed publication ID | 17350957 |
| P2093 | author name string | Jie Lu | |
| Edward V Prochownik | |||
| Youjun Li | |||
| P2860 | cites work | A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation | Q24299446 |
| Ubc9 interacts with SOX4 and represses its transcriptional activity | Q24319664 | ||
| Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1 | Q24656539 | ||
| SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex | Q24678180 | ||
| Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. | Q28117154 | ||
| HMGI/Y proteins: flexible regulators of transcription and chromatin structure | Q28201754 | ||
| Differential interactions of Id proteins with basic-helix-loop-helix transcription factors | Q28245175 | ||
| The negative c-Myc target onzin affects proliferation and apoptosis via its obligate interaction with phospholipid scramblase 1 | Q28587609 | ||
| Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C | Q28588994 | ||
| SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting | Q29619527 | ||
| Ubc9 interacts with chicken ovalbumin upstream promoter-transcription factor I and represses receptor-dependent transcription | Q30749768 | ||
| In vivo posttranslational modifications of the high mobility group A1a proteins in breast cancer cells of differing metastatic potential | Q33206483 | ||
| Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins | Q33209784 | ||
| Sumoylation induced by the Arf tumor suppressor: a p53-independent function | Q33821331 | ||
| Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells | Q33966952 | ||
| The HMG I proteins: dynamic roles in gene activation, development, and tumorigenesis | Q34085807 | ||
| Molecular biology of HMGA proteins: hubs of nuclear function | Q34095287 | ||
| PDSM, a motif for phosphorylation-dependent SUMO modification | Q34248164 | ||
| The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia. | Q34321598 | ||
| Role of the high mobility group A proteins in human lipomas | Q34384823 | ||
| Intracellular targeting of proteins by sumoylation | Q34430550 | ||
| Competition between HMG-I(Y), HMG-1 and histone H1 on four-way junction DNA. | Q34634739 | ||
| The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells | Q35007234 | ||
| Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification | Q35887800 | ||
| Molecular mechanism of HMGA1 deregulation in human neuroblastoma. | Q36143513 | ||
| Targeting Ubc9 for cancer therapy | Q36318546 | ||
| Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies | Q37291219 | ||
| High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity. | Q40341382 | ||
| p14ARF interacts with the SUMO-conjugating enzyme Ubc9 and promotes the sumoylation of its binding partners. | Q40426297 | ||
| C-Myc-independent restoration of multiple phenotypes by two C-Myc target genes with overlapping functions | Q40444185 | ||
| Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulation | Q40525051 | ||
| Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation | Q40570030 | ||
| HMG-I/Y in human breast cancer cell lines | Q40733016 | ||
| A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas | Q42796064 | ||
| Distinct Roles for MAX Protein Isoforms in Proliferation and Apoptosis | Q42798685 | ||
| Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression | Q42811126 | ||
| Identification of a substrate recognition site on Ubc9. | Q43904668 | ||
| High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase-2 expression in prostate cancer cells | Q47431419 | ||
| Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt-Mdm2-p53 pathway. | Q50754258 | ||
| Increased expression of high mobility group A proteins in lung cancer. | Q53633597 | ||
| Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. | Q54678305 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 13363-13371 | |
| P577 | publication date | 2007-03-09 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Dual role for SUMO E2 conjugase Ubc9 in modulating the transforming and growth-promoting properties of the HMGA1b architectural transcription factor | |
| P478 | volume | 282 |
| Q34939445 | A Novel Pathway that Links Caveolin-1 Down-Regulation to BRCA1 Dysfunction in Serous Epithelial Ovarian Cancer Cells |
| Q48222762 | Assessing predictions of fitness effects of missense mutations in SUMO-conjugating enzyme UBE2I. |
| Q94305238 | BRCA1 Mutation Leads to Deregulated Ubc9 Levels which Triggers Proliferation and Migration of Patient-Derived High Grade Serous Ovarian Cancer and Triple Negative Breast Cancer Cells |
| Q36206491 | BRCA1 proteins regulate growth of ovarian cancer cells by tethering Ubc9 |
| Q35624739 | Core promoter-selective function of HMGA1 and Mediator in Initiator-dependent transcription |
| Q37471156 | Polymorphism of UBC9 gene encoding the SUMO-E2-conjugating enzyme and breast cancer risk. |
| Q39125376 | Proteomic profile of maternal-aged blastocoel fluid suggests a novel role for ubiquitin system in blastocyst quality. |
| Q37001370 | Roles of HMGA proteins in cancer |
| Q47414975 | Ubc9 Binds to ADAP and Is Required for Rap1 Membrane Recruitment, Rac1 Activation, and Integrin-Mediated T Cell Adhesion |
| Q35898032 | Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteins |
Search more.